Clinical Trials Logo

Clinical Trial Summary

This study aims to compare the success rate of external dacryocystorhinostomy with and without amniotic membranes in patients with nasolacrimal duct obstruction.


Clinical Trial Description

Naso-lacrimal duct obstruction (NLDO) causes epiphora, recurrent dacryocystitis, and skin fistulas. Its incidence increases with age. Dacryocystorhinostomy (DCR) is considered the standard treatment for NLDO. Authors describe similar success rates between external or endoscopic approaches. The former uses a skin approach, through which an osteotomy is made, allowing access to the lacrimal sac and subsequently to the middle meatus of the nasal cavity. On the other hand, endoscopic surgery uses an endonasal route to create a fistula towards the lacrimal sac, with the benefit of not generating visible scars in patients. The success of both surgeries depends on creating a wide osteotomy and the preservation of the mucosa around it, reducing the risk of scarring and stenosis of the ostium formed. Some authors suggest that limiting the inflammatory process localized to the osteotomy may improve the surgical success rate. The use of mitomycin C (MMC) has been reported, with limited results due to variability in the concentration and methods of drug used. Amniotic membrane (AM) has been used in ophthalmology, such as in pterygium surgery, chemical trauma, and inflammatory diseases of the ocular surface. In these contexts, AM limits the inflammatory response, promotes re-epithelialization, and reduces fibrosis. AM epithelial cells do not express HLA-A, B, C, or DR antigens on their surface, and therefore do not present a risk of rejection by the immune system. This study aims to compare the success rate of external DCR with and without amniotic membranes in patients with NLDO. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06226181
Study type Interventional
Source Instituto de Oftalmología Fundación Conde de Valenciana
Contact Yonathan Garfias, MD, PhD
Phone +52(55)54421700
Email yogarfias@institutodeoftalmologia.org
Status Recruiting
Phase Phase 1
Start date January 1, 2024
Completion date March 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT00780741 - Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old Phase 3
Completed NCT00784992 - A Comparison of Endonasal Dacryocystorhinostomy With and Without Silicone Tubes Phase 4
Recruiting NCT06346561 - The Efficacy of Dexmedetomidine Versus Labetalol In Providing Controlled Hypotension In Dacryocystorhinostomy SurgeryA Comparative Randomized Prospective Study N/A
Completed NCT01233596 - Monocanalicular Versus Bicanalicular Intubation in the Treatment of Congenital Nasolacrimal Duct Obstruction Phase 3
Completed NCT00315289 - Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years Old Phase 3
Completed NCT00315315 - Study of Surgical Procedures for Treatment of Persistent Nasolacrimal Duct Obstruction in Children < 4 Years Old Phase 3
Recruiting NCT05999630 - Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer Phase 3
Completed NCT01766232 - Lacrimal Drainage Resistance Study N/A